Big Tech representative covering Group A

Today, I am focusing on only two major categories: First, biomedical innovation. The industry ETF IHI (iShares U.S. Medical Devices ETF) is currently at $58.57, up 10.95% over the past 20 days, 4.15% below its 20-day high, with a volume ratio of 0.79 and an RSI(14) of 64.5. This represents a post-pullback breakout observation. Representative stocks include $JNJ (Johnson & Johnson) and $SYK (Stryker). Second, AI hardware. The industry ETF QQQ (Nasdaq-100 ETF) is currently at $679.35, down 8.94% over the past 20 days, 4.75% above its 20-day low, with a volume ratio of 1.07 and an RSI(14) of 41.4. This represents a pullback phase. Representative stocks include $NVDA (NVIDIA), $MSFT (Microsoft), and $AAPL (Apple). If I were to select only three stocks, I would choose $JNJ (Group C, did not meet hard criteria for replacement), $NVDA (Group B, did not meet hard criteria for replacement), and $AAPL (Group A, did not meet hard criteria for replacement). These three cover Groups A, B, and C. $JNJ is ranked first because it is the only stock on the list showing a weekly breakout (positioned in the 99.3% range of its 52-week period, just 0.22% below its 52-week high) along with increased call option volume and a 102% surge in call trading volume. It offers the most complete alignment between events and capital flow. Today, I explicitly avoid: cold picks with no catalysts or capital inflow, stocks with a volume ratio under 1, stocks whose target prices cannot be verified, stocks relying solely on dividends or commodity price hikes, stocks lacking chip data, and stocks that are already crowded after significant gains and awaiting a retest.